Sodium Oxybate

7 trials 4 recruiting NNeurology/Psychiatry

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

5 Countries

Phase III

Phase II

Phase III/IV

Phase III: 2 Phase II: 4 Phase III/IV: 1

Indications tested

Bush-Francis catatonia rating scale 1 Catatonia 1

Sponsors using this IMP

Stichting Radboud University Medical Center 2 Aarhus Universitet 1 Academisch Ziekenhuis Leiden 1 Amsterdam UMC Stichting 1 Assistance Publique Hopitaux De Paris 1 Laboratorio Farmaceutico C.T. S.r.l. 1

All trials

7 total

Improving inpatient GHB detoxification with baclofen Not authorised

2023-506167-34-00 Phase II 1 country Stichting Radboud University Medical Center
Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients: A Pilot Double-Blind Randomized Controlled … Pending

2025-521967-11-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Sodium-oxybate as a potential new treatment for catatonia in patients with depression, bipolar disorder or a psychotic disorder, a randomize… Recruiting

2024-517805-10-01 Phase III 1 country Amsterdam UMC Stichting
Improving inpatient GHB detoxification with baclofen Recruiting

2023-506167-34-02 Phase II 1 country Stichting Radboud University Medical Center
Clear-Brain: stimulating amyloid clearance in cerebral amyloid angiopathy Recruiting

2023-506128-10-00 Phase II 1 country Academisch Ziekenhuis Leiden
Efficacy and safety of Sodium Oxybate in reducing alcohol consumption and maintaining abstinence in alcohol-dependent subjects with high and… Recruiting

2023-506990-37-00 Phase III 3 countries Laboratorio Farmaceutico C.T. S.r.l.
Detect GHB Ended

2022-501329-18-00 Phase III/IV 1 country Aarhus University

Showing 1–7 of 7 trials

← All drugs A–Z